Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis

ObjectiveTo assess and compare the incidence of venous thromboembolism (VTE) in patients with rheumatoid arthritis (RA) treated with Janus kinase inhibitors (JAKi), tumour necrosis factor inhibitors (TNFi) or other biological disease modifying antirheumatic drugs (bDMARDs). For contextualisation, to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of the rheumatic diseases 2023-02, Vol.82 (2), p.189-197
Hauptverfasser:	Molander, Viktor, Bower, Hannah, Frisell, Thomas, Delcoigne, Benedicte, Di Giuseppe, Daniela, Askling, Johan, Alenius, Gerd-Marie, Baecklund, Eva, Chatzidionysiou, Katerina, Feltelius, Nils, Forsblad-d’Elia, Helena, Kastbom, Alf, Klareskog, Lars, Knight, Ann, Lindqvist, Elisabet, Lindström, Ulf, Ljung, Lotta, Turesson, Carl, Sjöwall, Christopher
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants Antirheumatic Agents Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid Arthritis, Rheumatoid - drug therapy Cardiovascular Diseases Clinical medicine Cohort Studies Disease Embolism Epidemiology Humans Immunomodulation Immunosuppressive agents Janus kinase Janus Kinase Inhibitors - therapeutic use Patients Population Prescription drugs Pulmonary embolisms Rheumatoid Arthritis Rheumatology Surveillance Sweden - epidemiology Thromboembolism Thrombosis Tumor necrosis factor Tumor Necrosis Factor Inhibitors - therapeutic use Tumor necrosis factor-TNF Tumors Venous Thromboembolism - epidemiology
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!